GlassScriptPhysician profile
Matthew Perez
NPI 1821117847
$1,021.90
in general payments reported to CMS, 2019-2025
15 companies · $78.48 in 2025
The $78.48 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $50.31 · 2021: $32.00 · 2022: $162 · 2023: $395 · 2024: $67.37 · 2025: $78.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $381.99 | 2019-2025 | Clareon, Argos, Simbrinza |
| Bausch & Lomb Americas INC. | $136.62 | 2022-2023 | Envista Mx60 Iol, Vyzulta |
| Allergan, INC. | $81.15 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $75.62 | 2020-2024 | Veritas Vision System |
| Novartis Pharmaceuticals Corporation | $64.20 | 2019-2023 | |
| Abbvie INC. | $42.81 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.60 | 2019 | |
| Sun Pharmaceutical Industries INC. | $42.05 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $31.10 | 2025 | Dupixent |
| Oyster Point Pharma, INC. | $28.62 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $25.26 | 2019 | |
| Rayner Intraocular Lenses Limited | $24.54 | 2025 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| Horizon Therapeutics Plc | $15.48 | 2023 | Tepezza |
| Ocular Therapeutix, INC. | $14.96 | 2019 | |
| Shire North American Group INC | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.